BSE filing, NSE: SANPA. Summary written from the filing by ALFA Finder's alert engine.
Sangal Papers Ltd: key numbers
- Share price
- ₹189.70
- Market cap
- ₹24.80 Cr
- Revenue (annual)
- ₹179.3 Cr
- Net profit (annual)
- ₹2.37 Cr
- P/E (TTM)
- 5.8×Sector 43.1×
- Promoter holding
- 39.48%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sangal Papers Ltd
All →Sangal Papers Management Change
Sangal Papers intimated the demise of Cost Auditor CMA S.R. Kapur on October 18, 2026. The company will fill the casual vacancy within statutory timelines.
Sangal Papers Other Announcement
Sangal Papers Ltd filed an update regarding the administrative rectification of typographical errors in its Registered Office address on the MCA portal.
Sangal Papers Board Meeting Outcome
Sangal Papers Limited's board approved correcting clerical and typographical errors in its registered office address records. No physical shifting or relocation of the office has occurred.
Sangal Papers Legal & Regulatory
Sangal Papers Limited received a rectification order from the Income Tax Department for A.Y. 2025-2026. The order raises a tax demand of ₹0.15 Crore.
- Value
- ₹0.15 Cr
- From
- Income Tax Department
Sangal Papers Management Change
Sanjal Papers re-appointed Tanmay Sangal and Vinayak Sangal as Non-Executive Non-Independent Directors for 12 months effective September 2026. No financial impact accompanies this routine board compliance filing.
- Execution
- 12 months
Sangal Papers Annual General Meeting
Sangal Papers filed 46th AGM proceedings held 23 Sep 2026 via VC/OAVM. Routine items included FY26 financials adoption and two director re-appointments by rotation.
Other other announcement announcements
All →Milky Mist Dairy Food Other Announcement
Milky Mist's board appointed B Chandra & Associates as Secretarial Auditors for FY 2026-27 to 2030-31. Shareholder approval is pending at the ensuing AGM.
- Execution
- FY 2026-27 to FY 2030-31 (five years)
Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd, an SME-platform listed company, confirms non-applicability of Corporate Governance under Regulation 27(2) for the quarter ended 30 September 2026. A Company Secretary certificate is enclosed.
Wipro Other Announcement
Wipro disclosed a designated person's 34,200-share ADR sale worth about ₹0.67 Crore on 28 October 2026. The sale followed RSU exercise, leaving 60,266 securities held.
- Value
- ₹0.67 Cr
OK Play India Other Announcement
OK Play India filed its quarterly shareholding pattern for the quarter ended September 2026. It shows category holdings only, with no transaction.
Spice Islands Industries Other Announcement
Spice Islands Industries filed a Reg 32 statement reporting no deviation in preferential issue fund utilization for Q3 FY27. The ₹8.70 Crore raise is fully deployed.
Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.